When was Neogen founded?

Neogen was founded in 1982 and raised its 1st funding round 6 years after it was founded.

Where is Neogen located?

Neogen is headquartered in Lansing, United States. It is registered at Lansing, Michigan.

How many employees does Neogen have?

As of Jun 30, 2026, the latest employee count at Neogen is 2368.

Is Neogen a funded company?

Neogen is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jul 1988.

When was the latest funding round of Neogen?

Neogen's latest funding was a $***** Series A round on Jul 1988, with participation from 1 investor.

What is the annual revenue of Neogen?

Annual revenue of Neogen is between $500M and $1B as on May 31, 2025

Where does Neogen rank among its competitors?

Neogen ranks 7th amongst 283 active competitors, of which 47 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was RareCyte, which secured $658K in May, 2025.

Who are the top competitors of Neogen?

Neogen's top competitors include Qiagen, LGC and Parse Biosciences. Among them, RareCyte secured the most recent funding round in May, 2025.

Neogen - 2026 Company Profile, Funding, Competitors & Financials

Neogen is an acquired company based in Lansing (United States), founded in 1982. It operates as a Solutions for food and animal safety, diagnostics, and genomics. Neogen has raised $700K in funding from Innovative Ventures. The company has 283 active competitors, including 47 funded and 42 that have exited. Its top competitors include companies like Qiagen, LGC and Parse Biosciences.

Company Details

Solutions for food and animal safety, diagnostics, and genomics. The company provides a diverse suite of solutions for the food, beverage, animal, healthcare, public health, toxicology, university, research, and agriculture industries. It empowers customers to safeguard their brands and create better products through diagnostics and genomics. The company offers products and services related to adulteration, allergens, environmental monitoring, laboratory services, microbiology, mycotoxins, pathogens, sample collection, sanitation, hygiene, and water treatment. Brands include AccuPoint, Clean-Trace, Megazyme, and Neogen Analytics. The company also provides solutions for livestock, pet health, equine, and specialty healthcare, including environmental monitoring and IVD manufacturing. It offers reagents for immunoassays, DNA sampling equipment, DNA sequencing, and genotyping arrays. The website includes features such as a search box, login, cart, document search, digital catalogs, and customer support. It also provides access to webinars, blogs, videos, and other resources.

Website: www.neogen.com/
Social
Registered Address: Lansing, Michigan

Key Metrics

Founded Year

1982

Location

Lansing, United States

Stage

Acquired

Total Funding

$700K in 1 round

Latest Funding Round

Series A, Jul 1988, $*****

Investors

Innovative Ventures & 1 more

Ranked

7^th among 283 active competitors

Annual Revenue

$500M - $1B as on May 31, 2025

Employee Count

2,368 as on Jun 30, 2026

Investment & Acquisitions

Delf & 15 more

Similar Companies

Qiagen & 346 more

Exit Details

Acquired by Kersia (Apr 23, 2025)

View Neogen's full profile

Neogen is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NEOGEN CORP CIN: 711377 , United States, Active		$500M - $1B (As on May 31, 2025)	-	-
NEOGEN FOOD AND ANIMAL SECURITY (INDIA) PRIVATE LIMITED CIN: U74120KL2008PTC050404 , India, Active	Jan 14, 2008	₹10 - ₹50 Cr (As on Mar 31, 2025)	-
NEOGEN FOOD SAFETY UK LTD CIN: 14027492 , United Kingdom, Active	Apr 04, 2022	£10M - £50M (As on May 31, 2024)	81 (As on May 31, 2024)
Neogen Corporation CIN: 382367843 , United States, Active	Dec 26, 999	-	1716 (As on Dec 31, 2024)	-
NEOGEN EUROPE LIMITED CIN: SC186341 , United Kingdom, Active	Jun 01, 1998	£10M - £50M (As on May 31, 2025)	226 (As on May 31, 2025)

Neogen got acquired by Kersia on Apr 23, 2025.

Click here to take a look at Neogen's acquisition in detail

Neogen has raised a total funding of $700K over 1 round. Its latest funding round was a Series A round on Jul 1988 for $*****. 1 investor participated in its latest round. Neogen has 2 institutional investors.

Here is the list of recent funding rounds of Neogen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 1988	8433012	Series A	6677495	2104411	5595639	5227868

Access funding benchmarks and valuations. Sign up today!

View details of Neogen's funding rounds and investors

Neogen's employee count trend

Neogen has 2,368 employees as of Jun 26. Here is Neogen's employee count trend over the years:

Uncover Neogen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neogen include Qiagen, LGC and Parse Biosciences. Here is the list of Top 10 competitors of Neogen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qiagen 1984, Venlo (Netherlands), Acquired	Provider of products and reagents for molecular diagnostic assays	-	Life Sciences Partners, Harmonic & 6 others	65/100
2nd	LGC 1842, Teddington (United Kingdom), Acquired	Provider of analytical testing, reference materials, and diagnostic and therapeutic products	-	Broad Vision Funds, AlpInvest Partners & 4 others	65/100
3rd	Parse Biosciences 2018, Seattle (United States), Series C	Developer of RNA-sequencing solution-based transcriptome kit to analyze health data	$100M	Marshall Wace, Janus Henderson Investors & 8 others	64/100
4th	Paragon Genomics 2015, San Francisco (United States), Series A	Provider of technologies and solutions genomic research and precision medicine	$8M	Fosun·Star Future Capital, Co-win Ventures ... & 3 others	62/100
5th	seqWell 2014, Beverly (United States), Series C	Provider of NGS-based reagents and kits for life sciences research	$24.5M	RCT, Codexis & 3 others	60/100
6th	RareCyte 2009, Seattle (United States), Series C	Developer of technologies for the analysis of rare and single cells in the blood	$114M	Arboretum Ventures, F-Prime Capital & 11 others	57/100
7th	Neogen 1982, Lansing (United States), Acquired	Solutions for food and animal safety, diagnostics, and genomics	$700K	NISA, Innovative Ventures	57/100
8th	Sebia 1967, Evry Courcouronnes (France), Acquired	Developer of electrophoresis-based in vitro diagnostics products	-	HarbourVest Partners, Astorg Partners & 4 others	56/100
9th	Genomtec 2016, Wroclaw (Poland), Series A	Provider of handheld POC device for nucleic acid testing	$4.38M	KnowledgeHub, NRDC & 5 others	55/100
10th	NuProbe 2016, George Town (Cayman Islands), Series B	Develops sensitive multiplex tool for QPCR	$61M	Sequoia Capital, Yonghua Capital & 14 others	51/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Neogen's competitors? Click here to see the top ones

Neogen has made 2 investments in companies including Frisbo and Sailo. Neogen has also acquired 14 companies including Delf and Megazyme.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Dec 01, 2021	Acquisition	Delf	2006	Birkenhead (United Kingdom)
Jan 04, 2021	Acquisition	Megazyme	1988	Bray (Ireland)
Apr 02, 2020	Acquisition	Magiar Chilena	1998	Chile